Advertisement
BWAY vs DCTH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Buy and DCTH is a Buy.
BWAY's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for BWAY turned positive on October 19, 2026. Looking at past instances where BWAY's MACD turned positive, the stock continued to rise in 45 of 49 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BWAY's RSI Indicator exited the oversold zone, 13 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 57 cases where BWAY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +9.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWAY advanced for three days, in 219 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
BWAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BWAY as a result. In 82 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for BWAY entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. BWAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.666) is normal, around the industry mean (4.142). P/E Ratio (44.600) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (8.681) is also within normal values, averaging (40.124).
DCTH in upward trend: 10-day moving average broke above 50-day moving average on November 10, 2026
The 10-day moving average for DCTH crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on DCTH as a result. In 73 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for DCTH just turned positive on November 04, 2026. Looking at past instances where DCTH's MACD turned positive, the stock continued to rise in 32 of 39 cases over the following month. The odds of a continued upward trend are 82%.
DCTH moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +39.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where DCTH advanced for three days, in 198 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
DCTH broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DCTH entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. DCTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.276) is normal, around the industry mean (4.142). DCTH's P/E Ratio (1493.000) is considerably higher than the industry average of (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (6.757) is also within normal values, averaging (40.124).
BWAY | DCTH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 66 | 37 | |
SMR RATING 1..100 | 62 | 90 | |
PRICE GROWTH RATING 1..100 | 63 | 35 | |
P/E GROWTH RATING 1..100 | 68 | 2 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BWAY's Valuation (83) in the Medical Specialties industry is in the same range as DCTH (97). This means that BWAY’s stock grew similarly to DCTH’s over the last 12 months.
DCTH's Profit vs Risk Rating (37) in the Medical Specialties industry is in the same range as BWAY (66). This means that DCTH’s stock grew similarly to BWAY’s over the last 12 months.
BWAY's SMR Rating (62) in the Medical Specialties industry is in the same range as DCTH (90). This means that BWAY’s stock grew similarly to DCTH’s over the last 12 months.
DCTH's Price Growth Rating (35) in the Medical Specialties industry is in the same range as BWAY (63). This means that DCTH’s stock grew similarly to BWAY’s over the last 12 months.
DCTH's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for BWAY (68). This means that DCTH’s stock grew significantly faster than BWAY’s over the last 12 months.
| BWAY | DCTH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 65% | 2 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 74% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 77% | 2 days ago 84% |
| Advances ODDS (%) | 4 days ago 84% | 4 days ago 80% |
| Declines ODDS (%) | 11 days ago 77% | 14 days ago 79% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 73% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 82% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BWAY’s FA Score shows that 0 FA rating(s) are green while DCTH’s FA Score has 1 green FA rating(s).
- BWAY’s FA Score: 0 green, 5 red.
- DCTH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BWAY’s TA Score shows that 5 TA indicator(s) are bullish while DCTH’s TA Score has 5 bullish TA indicator(s).
- BWAY’s TA Score: 5 bullish, 3 bearish.
- DCTH’s TA Score: 5 bullish, 5 bearish.
Price Growth
BWAY (@Medical/Nursing Services) experienced а +0.27% price change this week, while DCTH (@Medical/Nursing Services) price change was +46.90% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +5.70%. For the same industry, the average monthly price growth was -2.49%, and the average quarterly price growth was -1.73%.
Reported Earning Dates
BWAY is expected to report earnings on Mar 17, 2027.
DCTH is expected to report earnings on Mar 30, 2027.
Industries' Descriptions
@Medical/Nursing Services (+5.70% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
BWAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with DCTH. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then DCTH could also see price increases.
| Ticker / NAME | Correlation To BWAY | 1D Price Change % | ||
|---|---|---|---|---|
| BWAY | 100% | +5.34% | ||
| DCTH - BWAY | 34% Loosely correlated | +8.31% | ||
| MBOT - BWAY | 33% Poorly correlated | +5.71% | ||
| ISRG - BWAY | 31% Poorly correlated | -0.11% | ||
| TCMD - BWAY | 31% Poorly correlated | +1.92% | ||
| QSI - BWAY | 30% Poorly correlated | -0.78% | ||
More | ||||
DCTH and
Correlation & Price change
A.I.dvisor indicates that over the last year, DCTH has been loosely correlated with NVST. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DCTH jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To DCTH | 1D Price Change % | ||
|---|---|---|---|---|
| DCTH | 100% | +8.31% | ||
| NVST - DCTH | 38% Loosely correlated | -2.01% | ||
| PRCT - DCTH | 37% Loosely correlated | +1.26% | ||
| SGHT - DCTH | 37% Loosely correlated | +1.58% | ||
| CERS - DCTH | 35% Loosely correlated | +8.72% | ||
| BWAY - DCTH | 34% Loosely correlated | +5.34% | ||
More | ||||